Literature DB >> 22665364

Haematological cancer: Lenalidomide maintenance--perils of a premature denouement.

S Vincent Rajkumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22665364     DOI： 10.1038/nrclinonc.2012.100

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Lenalidomide in myeloma--a high-maintenance friend.

Authors:  Ashraf Z Badros
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

2.  Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.

Authors:  Michel Attal; Jean-Luc Harousseau; Serge Leyvraz; Chantal Doyen; Cyrille Hulin; Lofti Benboubker; Ibrahim Yakoub Agha; Jean-Henri Bourhis; Laurent Garderet; Brigitte Pegourie; Charles Dumontet; Marc Renaud; Laurent Voillat; Christian Berthou; Gerald Marit; Mathieu Monconduit; Denis Caillot; Bernard Grobois; Herve Avet-Loiseau; Philippe Moreau; Thierry Facon
Journal:  Blood       Date:  2006-07-27       Impact factor: 22.113

3.  Multiple myeloma and the road to personalised medicine.

Authors:  Stephen J Russell; S Vincent Rajkumar
Journal:  Lancet Oncol       Date:  2011-06-12       Impact factor: 41.316

4.  Approach to the treatment of multiple myeloma: a clash of philosophies.

Authors:  S Vincent Rajkumar; Gösta Gahrton; P Leif Bergsagel
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

5.  Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.

Authors:  Shaji Kumar; Rafael Fonseca; Rhett P Ketterling; Angela Dispenzieri; Martha Q Lacy; Morie A Gertz; Suzanne R Hayman; Francis K Buadi; David Dingli; Ryan A Knudson; Alexandra Greenberg; Stephen J Russell; Steven R Zeldenrust; John A Lust; Robert A Kyle; Leif Bergsagel; S Vincent Rajkumar
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

Review 6.  Treatment of multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

7.  Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.

Authors:  Andrew Spencer; H Miles Prince; Andrew W Roberts; Ian W Prosser; Kenneth F Bradstock; Luke Coyle; Devinder S Gill; Noemi Horvath; John Reynolds; Nola Kennedy
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

8.  Continuous lenalidomide treatment for newly diagnosed multiple myeloma.

Authors:  Antonio Palumbo; Roman Hajek; Michel Delforge; Martin Kropff; Maria Teresa Petrucci; John Catalano; Heinz Gisslinger; Wiesław Wiktor-Jędrzejczak; Mamia Zodelava; Katja Weisel; Nicola Cascavilla; Genadi Iosava; Michele Cavo; Janusz Kloczko; Joan Bladé; Meral Beksac; Ivan Spicka; Torben Plesner; Joergen Radke; Christian Langer; Dina Ben Yehuda; Alessandro Corso; Lindsay Herbein; Zhinuan Yu; Jay Mei; Christian Jacques; Meletios A Dimopoulos
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

9.  Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Authors:  Michel Attal; Valerie Lauwers-Cances; Gerald Marit; Denis Caillot; Philippe Moreau; Thierry Facon; Anne Marie Stoppa; Cyrille Hulin; Lofti Benboubker; Laurent Garderet; Olivier Decaux; Serge Leyvraz; Marie-Christiane Vekemans; Laurent Voillat; Mauricette Michallet; Brigitte Pegourie; Charles Dumontet; Murielle Roussel; Xavier Leleu; Claire Mathiot; Catherine Payen; Hervé Avet-Loiseau; Jean-Luc Harousseau
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

10.  Lenalidomide after stem-cell transplantation for multiple myeloma.

Authors:  Philip L McCarthy; Kouros Owzar; Craig C Hofmeister; David D Hurd; Hani Hassoun; Paul G Richardson; Sergio Giralt; Edward A Stadtmauer; Daniel J Weisdorf; Ravi Vij; Jan S Moreb; Natalie Scott Callander; Koen Van Besien; Teresa Gentile; Luis Isola; Richard T Maziarz; Don A Gabriel; Asad Bashey; Heather Landau; Thomas Martin; Muzaffar H Qazilbash; Denise Levitan; Brian McClune; Robert Schlossman; Vera Hars; John Postiglione; Chen Jiang; Elizabeth Bennett; Susan Barry; Linda Bressler; Michael Kelly; Michele Seiler; Cara Rosenbaum; Parameswaran Hari; Marcelo C Pasquini; Mary M Horowitz; Thomas C Shea; Steven M Devine; Kenneth C Anderson; Charles Linker
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245
  10 in total
  7 in total

1.  Lenalidomide maintenance in myeloma.

Authors:  Alessandro Gozzetti; Marzia Defina; Monica Bocchia
Journal:  Nat Rev Clin Oncol       Date:  2012-09-04       Impact factor: 66.675

Review 2.  Minimal residual disease in acute myeloid leukaemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

3.  Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.

Authors:  Brian L Burnette; Angela Dispenzieri; Shaji Kumar; Ann M Harris; Jeff A Sloan; Jon C Tilburt; Robert A Kyle; S Vincent Rajkumar
Journal:  Cancer       Date:  2013-09-19       Impact factor: 6.860

Review 4.  Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  S Vincent Rajkumar
Journal:  Am J Hematol       Date:  2016-07       Impact factor: 10.047

Review 5.  Myeloma today: Disease definitions and treatment advances.

Authors:  S Vincent Rajkumar
Journal:  Am J Hematol       Date:  2016-01       Impact factor: 10.047

Review 6.  Multiple Myeloma: Diagnosis and Treatment.

Authors:  S Vincent Rajkumar; Shaji Kumar
Journal:  Mayo Clin Proc       Date:  2016-01       Impact factor: 7.616

Review 7.  Therapeutic advancements in multiple myeloma.

Authors:  Alessandro Gozzetti; Veronica Candi; Giulia Papini; Monica Bocchia
Journal:  Front Oncol       Date:  2014-09-04       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.